逆势加仓！资金涌入这一方向

Group 1 - The core market products were actively traded last week, with A500ETF (159361) and other ETFs tracking the CSI A500 index having a total trading volume exceeding 130 billion yuan [1][6] - The Hong Kong stock market saw a rise in the innovative pharmaceutical sector, with the Hang Seng Innovation Drug ETF (159316) index increasing by over 8% last week [2][4] - The technology sector experienced a pullback, but ETFs focused on technology themes attracted significant capital inflows, with the STAR 50 ETF (588080) seeing a net inflow of 2.3 billion yuan [8][11] Group 2 - The overall market showed signs of structural recovery, supported by economic resilience and favorable policies, indicating that A-shares may continue a steady upward trend [3][11] - The trading volume of ETFs tracking the ChiNext, STAR Market, and CSI 300 indices was notably high, with the STAR 50 ETF (588080) and ChiNext ETF (159915) among the top performers [6][7] - The Hang Seng Dividend Low Volatility ETF (159545) announced its fourth dividend distribution this year, reflecting a consistent dividend policy [10] Group 3 - The innovative pharmaceutical and gold sectors led the market gains, with several ETFs in these categories showing significant weekly increases [4][5] - The net inflow of capital into technology and high-dividend sectors was substantial, with the Hang Seng Innovation Drug ETF (159316) and Hang Seng Dividend Low Volatility ETF (159545) receiving considerable attention [8][9] - The macroeconomic environment is expected to remain stable, with a focus on high-quality development and long-term growth policies, enhancing the attractiveness of A-shares and Hong Kong stocks for medium to long-term investments [11]